Who took part in this study?
The researchers asked for the help of men and women with advanced or
metastatic non-small cell lung cancer, also called “NSCLC”.
The participants also:
X had never received chemotherapy for this condition.
X had a life expectancy of at least 12 weeks at the start of the study.
X had no changes in genes called “epidermal growth factor receptor” and
“anaplastic lymphoma kinase” in their tumors.
The participants in this study were 27 to 90 years old when they joined.
The study included participants in Argentina, Brazil, Bulgaria, Chile, China,
Denmark, Finland, Greece, Hong Kong, India, Israel, Japan, Malaysia, Mexico,
Peru, the Philippines, Poland, Portugal, Qatar, Romania, Russia, Saudi Arabia,
Singapore, South Korea, Sweden, Turkey, Ukraine, the United Kingdom, and the
United States.
The study had 2 groups:
X The Global group included 823 participants from across the world.
X The China group included 160 participants from China, who joined the
study later than participants in the Global group.
4 | Clinical Study Results